Nanthip Prathumsap

468 total citations
22 papers, 355 citations indexed

About

Nanthip Prathumsap is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nanthip Prathumsap has authored 22 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 10 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nanthip Prathumsap's work include Chemotherapy-induced cardiotoxicity and mitigation (12 papers), Cancer-related cognitive impairment studies (7 papers) and Vagus Nerve Stimulation Research (4 papers). Nanthip Prathumsap is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (12 papers), Cancer-related cognitive impairment studies (7 papers) and Vagus Nerve Stimulation Research (4 papers). Nanthip Prathumsap collaborates with scholars based in Thailand. Nanthip Prathumsap's co-authors include Siriporn C. Chattipakorn, Krekwit Shinlapawittayatorn, Chayodom Maneechote, Titikorn Chunchai, Nipon Chattipakorn, Thawatchai Khuanjing, Benjamin Ongnok, Apiwan Arinno, Nipon Chattipakorn and Busarin Arunsak and has published in prestigious journals such as Circulation, International Journal of Molecular Sciences and European Heart Journal.

In The Last Decade

Nanthip Prathumsap

22 papers receiving 354 citations

Peers

Nanthip Prathumsap
Apiwan Arinno Thailand
Richa Aishwarya United States
Yi‐Tang Tseng United States
Jennifer Ramil United States
Amy D. Hanna United States
Maodi Xie China
Apiwan Arinno Thailand
Nanthip Prathumsap
Citations per year, relative to Nanthip Prathumsap Nanthip Prathumsap (= 1×) peers Apiwan Arinno

Countries citing papers authored by Nanthip Prathumsap

Since Specialization
Citations

This map shows the geographic impact of Nanthip Prathumsap's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nanthip Prathumsap with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nanthip Prathumsap more than expected).

Fields of papers citing papers by Nanthip Prathumsap

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nanthip Prathumsap. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nanthip Prathumsap. The network helps show where Nanthip Prathumsap may publish in the future.

Co-authorship network of co-authors of Nanthip Prathumsap

This figure shows the co-authorship network connecting the top 25 collaborators of Nanthip Prathumsap. A scholar is included among the top collaborators of Nanthip Prathumsap based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nanthip Prathumsap. Nanthip Prathumsap is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maneechote, Chayodom, Thawatchai Khuanjing, Benjamin Ongnok, et al.. (2025). Targeting mitochondrial dynamics emerges as an effective strategy of cardioprotection against trastuzumab-induced mitochondrial functional aberrations and cardiotoxicity in rats. European Journal of Pharmacology. 999. 177685–177685. 3 indexed citations
2.
Prathumsap, Nanthip, Benjamin Ongnok, Thawatchai Khuanjing, et al.. (2024). Muscarinic and nicotinic receptors stimulation by vagus nerve stimulation ameliorates trastuzumab-induced cardiotoxicity via reducing programmed cell death in rats. Toxicology and Applied Pharmacology. 491. 117074–117074. 3 indexed citations
3.
Ongnok, Benjamin, Nanthip Prathumsap, Titikorn Chunchai, et al.. (2024). Nicotinic and Muscarinic Acetylcholine Receptor Agonists Counteract Cognitive Impairment in a Rat Model of Doxorubicin-Induced Chemobrain via Attenuation of Multiple Programmed Cell Death Pathways. Molecular Neurobiology. 61(11). 8831–8850. 3 indexed citations
4.
Prathumsap, Nanthip, Benjamin Ongnok, Thawatchai Khuanjing, et al.. (2023). Acetylcholine receptor agonists effectively attenuated multiple program cell death pathways and improved left ventricular function in trastuzumab-induced cardiotoxicity in rats. Life Sciences. 329. 121971–121971. 4 indexed citations
5.
Ongnok, Benjamin, Nanthip Prathumsap, Thawatchai Khuanjing, et al.. (2023). Vagus Nerve Stimulation Provides Neuroprotection Against Doxorubicin‐induced Chemobrain Via Activations of Both Muscarinic and Nicotinic Acetylcholine Receptors. Alzheimer s & Dementia. 19(S13). 2 indexed citations
6.
Maneechote, Chayodom, Thawatchai Khuanjing, Benjamin Ongnok, et al.. (2023). Potential roles of 4HNE-adducted protein in serum extracellular vesicles as an early indicator of oxidative response against doxorubicin-induced cardiomyopathy in rats. Current Research in Toxicology. 5. 100134–100134. 2 indexed citations
7.
Khuanjing, Thawatchai, Chayodom Maneechote, Benjamin Ongnok, et al.. (2023). Acetylcholinesterase inhibition protects against trastuzumab-induced cardiotoxicity through reducing multiple programmed cell death pathways. Molecular Medicine. 29(1). 123–123. 9 indexed citations
8.
Khuanjing, Thawatchai, Chayodom Maneechote, Benjamin Ongnok, et al.. (2023). Vagus nerve stimulation and acetylcholinesterase inhibitor donepezil provide cardioprotection against trastuzumab-induced cardiotoxicity in rats by attenuating mitochondrial dysfunction. Biochemical Pharmacology. 217. 115836–115836. 8 indexed citations
9.
Maneechote, Chayodom, Thawatchai Khuanjing, Benjamin Ongnok, et al.. (2023). Upregulation of mitochondrial fusion as potential cardioprotective strategies against trastuzumab-induced cardiotoxicity in rats. European Heart Journal. 44(Supplement_2). 1 indexed citations
10.
Prathumsap, Nanthip, Benjamin Ongnok, Thawatchai Khuanjing, et al.. (2022). Vagus nerve stimulation exerts cardioprotection against doxorubicin-induced cardiotoxicity through inhibition of programmed cell death pathways. Cellular and Molecular Life Sciences. 80(1). 21–21. 18 indexed citations
11.
Maneechote, Chayodom, Thawatchai Khuanjing, Benjamin Ongnok, et al.. (2022). Promoting mitochondrial fusion in doxorubicin-induced cardiotoxicity: a novel therapeutic target for cardioprotection. Clinical Science. 136(11). 841–860. 23 indexed citations
12.
Arinno, Apiwan, Chayodom Maneechote, Thawatchai Khuanjing, et al.. (2022). Melatonin and metformin ameliorated trastuzumab-induced cardiotoxicity through the modulation of mitochondrial function and dynamics without reducing its anticancer efficacy. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1869(2). 166618–166618. 13 indexed citations
13.
Chunchai, Titikorn, Apiwan Arinno, Benjamin Ongnok, et al.. (2022). Ranolazine alleviated cardiac/brain dysfunction in doxorubicin-treated rats. Experimental and Molecular Pathology. 127. 104818–104818. 13 indexed citations
14.
Maneechote, Chayodom, Thawatchai Khuanjing, Benjamin Ongnok, et al.. (2022). Extracellular Vesicles Released after Doxorubicin Treatment in Rats Protect Cardiomyocytes from Oxidative Damage and Induce Pro-Inflammatory Gene Expression in Macrophages. International Journal of Molecular Sciences. 23(21). 13465–13465. 7 indexed citations
15.
Chunchai, Titikorn, Hiranya Pintana, Apiwan Arinno, et al.. (2022). Melatonin and metformin counteract cognitive dysfunction equally in male rats with doxorubicin-induced chemobrain. NeuroToxicology. 94. 158–171. 7 indexed citations
16.
Arinno, Apiwan, Chayodom Maneechote, Thawatchai Khuanjing, et al.. (2021). Abstract 9375: Melatonin and Metformin Exert Cardioprotection Against Trastuzumab-induced Cardiotoxicity Through Modulating Cardiac Mitochondrial Dynamics in Rats. Circulation. 144(Suppl_1). 1 indexed citations
17.
Khuanjing, Thawatchai, Benjamin Ongnok, Chayodom Maneechote, et al.. (2021). Acetylcholinesterase inhibitor ameliorates doxorubicin-induced cardiotoxicity through reducing RIP1-mediated necroptosis. Pharmacological Research. 173. 105882–105882. 56 indexed citations
18.
Prathumsap, Nanthip, Benjamin Ongnok, Thawatchai Khuanjing, et al.. (2021). Acetylcholine receptor agonists provide cardioprotection in doxorubicin-induced cardiotoxicity via modulating muscarinic M2 and α7 nicotinic receptor expression. Translational research. 243. 33–51. 16 indexed citations
19.
Arinno, Apiwan, Chayodom Maneechote, Thawatchai Khuanjing, et al.. (2021). Cardioprotective effects of melatonin and metformin against doxorubicin-induced cardiotoxicity in rats are through preserving mitochondrial function and dynamics. Biochemical Pharmacology. 192. 114743–114743. 72 indexed citations
20.
Prathumsap, Nanthip, Krekwit Shinlapawittayatorn, Siriporn C. Chattipakorn, & Nipon Chattipakorn. (2019). Effects of doxorubicin on the heart: From molecular mechanisms to intervention strategies. European Journal of Pharmacology. 866. 172818–172818. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026